- Overview
- Products
- Negative Pressure Wound Therapy
- Wound Dressing and Compression
- 3M Prevena Therapy
- Patient Warming
- Skin & Wound Care
- Securement
- Patient Monitoring
- Antimicrobial Incise Drapes
- Sterilization and Monitoring
- All Products
- PREVENTION
- Decontamination & Sterilisation
- Hypothermia Prevention & Patient Warming
- Reducing Skin Recolonisation
- Skin protection
- Vascular Access Solutions
- Surgical Site Infection Prevention
- Operating Room Solutions
- Peripheral IV Complications
- Care for oncology patients with catheter
- Prevention - all
- TREATMENT
- Pressure Injuries
- Diabetic Foot Ulcer Treatment
- Venous Leg Ulcers
- Traumatic Wounds
- Oedema and Lymphoedema
- Exudate Management
- Post-op Healing Solutions
- Treatment - all
- Resources
- Contact Us
- FAQs
- How to prepare yourself for surgery
- Instruction for Use
- Industry Insights
- Science of Medical Diagnostics
- All Resources
- EDUCATION
Prevena Central for cardiothoracic surgery
The Power to Protect with 3M™ Prevena™ Therapy
-
Reduced rate of SSI compared to standard of care1
90-day post-operatively
4% (3/75) Prevena Therapy vs.
16% (12/75) SOC (p=0.0266)* -
Reduced rate of wound infection with gram-positive skin flora1,*
90-day post-operatively
1.3% (1/75) Prevena Therapy vs.
13.3% (10/75) SOC (p=0.0090)* -
Primary wound closure at day 6/7 on removal2*
30-day post-operatively
98.7% (234/237) Prevena Therapy
-
Calculations are derived based on relative patient group incidence rate reported in this study.
*Statistically significant (p<0.05).
Proactive Risk Management (PRM) with Prevena Therapy
Implement PRM to help protect your high-risk patients. See the evidence behind the use of Prevena Therapy in cardiothoracic surgery.
-
Prevena Therapy is supported by more than 200 peer reviewed publications, with more being published every year. Download our easy to digest summary of the relevant clinical and health economic evidence to support the use of Prevena Therapy in cardiothoracic surgery.
-
Patient and procedure risk stratificationPrevena Therapy can benefit all surgical patients—but choosing Prevena Therapy for your high-risk patients can lead to improved outcomes and significant cost savings. Our Proactive Risk Management (PRM) guides will help you to select the right patients, and the right procedures , helping you to optimise outcomes.
-
Clinical compendiumWith over 200 peer reviewed publications studying Prevena Therapy, there is now sufficient evidence to provide evidence-based guidance to help support surgeon’s decision making.
Request a trial today
Contact us to request a trial and consultation with a 3M clinical specialist
Surgeon testimonials
Ready to try Prevena Therapy?
Our apologies...
An error has occurred while submitting. Please try again later...
Thank you!
Your form was submitted successfully
NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. This material is intended for healthcare professionals.
References
- Grauhan O, et al. Prevention of post sternotomy wound infections in obese patients by negative pressure wound therapy. J Thorac Cardiovasc Surg. 2013;145:1387-1392.
- Grauhan O, et al. Effect of surgical incision management on wound infections in a post sternotomy patient population. Int Wound J. 2014;11:6-9.
